Pfizer, Johnson & Johnson, and AstraZeneca—three of the world’s top coronavirus vaccine manufacturers—have paid out a combined $26 billion in dividends and stock buybacks to their shareholders over the past year, a sum that could fully fund the cost of inoculating Africa’s entire 1.3 billion-person population.
That’s according to an analysis released Thursday morning by the People’s Vaccine Alliance, a coalition of advocacy organizations campaigning to end massive inequities in the distribution of life-saving coronavirus vaccines.
){kind=link}